Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Corneal Findings in Patients Treated With Belantamab Mafodotin - a Prospective Study Focusing on Corneal Nerves

NCT05833737 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.

NCT NCT05833737
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05833737 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Corneal Findings in Patients Treated With Belantamab Mafodotin - a Prospective Study Focusing on Corneal Nerves
Lead sponsor
Medical University of Vienna
Phase
Observational
Overall status
Terminated
Start date
June 1, 2023
Completion date
January 1, 2025
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

corneal cyst, corneal diseases, multiple myeloma